Investor Presentation H1 2023

63 Investor presentation First six months of 2023 Global obesity market growth has been accelerating with Novo. Nordisk capturing the majority of growth 180% 140% 100% 60% Obesity market growth and Novo Nordisk value market share Obesity market size and growth DKK billion 180% 128% 108% 140% 100% 20.1 92% 60% 21.5 ~108% 41.6 0.1 92% ~128% 20% 20% 84% -20% -20% May May May NN Obesity care Others 2020 -NN market share 2023 2022 -Market growth (right axis) Novo Nordisk NN Growth (right axis) Source: IQVIA, May 2023 Value MAT, all countries; Share of growth not depicted due to high growth May 2023 Others Novo NordiskⓇ

View entire presentation